CytoReason Revenue
Biotechnology Research • 
Tel Aviv, Tel-Aviv District, Israel • 101-200 Employees
CytoReason revenue & valuation
| Annual revenue | $2,000,000 |
| Revenue per employee | $17,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $6,400,000 |
| Total funding | $100,000,000 |
Key Contacts at CytoReason
Amihay Gonen
Director Of Engineering, Data Department
David Harel
Co-Founder And Ceo
Tali Bonjack
Senior Director Human Resources
Liat Dassa
Director Of Product Planning
Avital Drabkin
Product Owner
Elina Starosvetsky
Vp Scientific Alliances And Co-Founder
Yana Bronstein Nidam
Director Of Finance & Accounting
Lilach Ofek
Senior Director Of Product Management
Ronen Schuster
Director Science Operations
Renee Yakira Kaly
Corporate Social Responsibility Director
Company overview
| Headquarters | Tel Aviv, Tel-Aviv District, Israel |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Cancer Immunotherapy, Data Science, Artificial Intelligence, Bioinformatics, Machine Learning, Biomarker Discovery, Immune System, Target Discovery, Atopic Dermatitis, Indications, Inflammatory Bowel Disease, Cells, Patient Stratification, Combinations, Computational Drug Discovery, Indication Prioritisation |
| Founded | 2016 |
| Employees | 101-200 |
| Socials |
CytoReason Email Formats
CytoReason uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@cytoreason.com), used 58.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@cytoreason.com | 58.4% |
{first initial}.{last name} | j.doe@cytoreason.com | 41.6% |
About CytoReason
CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases – tissue by tissue and cell by cell. Researchers of all levels rely on CytoReason’s technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain valuable tools to manage and optimize entire drug portfolios.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
CytoReason has 65 employees across 14 departments.
Departments
Number of employees
Funding Data
Explore CytoReason's funding history, including investment rounds, total capital raised, and key backers.
CytoReason Tech Stack
Discover the technologies and tools that power CytoReason's digital infrastructure, from frameworks to analytics platforms.
Security
WordPress plugins
Cookie compliance
JavaScript libraries
JavaScript libraries
WordPress themes
Page builders
JavaScript libraries
Font scripts
JavaScript libraries
Analytics
United Kingdom
United States
Australia
Canada
New ZealandFrequently asked questions
4.8
40,000 users
